Mark Spain, a veteran broadcaster who dedicated decades to anchoring the news in cities such as Indianapolis, Cleveland, and ...

Joey Wasson knew what he was facing when what doctors first thought was pancreatitis turned out to be pancreatic cancer.

The Russian mRNA vaccine under development can be “personalised” based on the genetic analysis of each person’s tumour to ...

Mark Spain, 64, who spent decades anchoring the news in Indianapolis, Cleveland, and Jacksonville, died on Dec. 18.

HMBD-001 is under clinical development by Hummingbird Bioscience and currently in Phase I for Pancreatic Ductal Adenocarcinoma.

Azacitidine is under clinical development by Bristol-Myers Squibb and currently in Phase II for Pancreatic Ductal Adenocarcinoma.

With breakthroughs from melanoma to pancreatic cancer, this has been a year of great promise in the field of cancer vaccines.